EFFICACY AND SAFETY OF EBRONUCIMAB, IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III CLINICAL STUDY

被引：0
|
作者：
Huo, Y. [1 ]
Zheng, B. [1 ]
Xia, Y. [2 ]
Wang, M. [2 ]
Li, B. [2 ]
Ni, X. [2 ]
Wang, G. [2 ]
Yu, B. [2 ]
机构：
[1] Peking Univ First Hosp, Cardiovasc, Beijing, Peoples R China
[2] Akeso Biopharma Inc, Clin Dept, Zhongshan, Peoples R China
来源：
ATHEROSCLEROSIS | 2023年 / 379卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P608
引用
收藏
页码：S198 / S199
页数：2
相关论文
共 50 条
  • [1] Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
    Zhang, Yanyan
    Pei, Zhaohui
    Chen, Beijian
    Qu, Yanling
    Dong, Xiaolin
    Yu, Binge
    Wang, Guoqin
    Xu, Fang
    Lu, Dongmei
    He, Zhimei
    Chen, Benchao
    Ma, Lei
    Wang, Max
    Li, Baiyong
    Xia, Michelle
    Zheng, Bo
    Huo, Yong
    PHARMACOLOGICAL RESEARCH, 2024, 207
  • [2] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [3] Efficacy and Safety of Ebronucimab, a Monoclonal Antibody Against Pcsk9, in Patients With Hyperlipidemia: Result From a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Zhen, Wang
    Pei, Zhaohui
    Chen, Jiyan
    Zhang, Guogang
    Li, Dongye
    Xia, Yu
    Li, Baiyong
    Wang, Max
    Ni, Xiang
    Wang, Guoqin
    Ge, Junbo
    CIRCULATION, 2022, 146
  • [4] Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: A randomized, double-blind, placebo-controlled trial
    Goldberg, AC
    Sapre, A
    Liu, J
    Capece, R
    Mitchel, YB
    MAYO CLINIC PROCEEDINGS, 2004, 79 (05) : 620 - 629
  • [5] Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial
    Germing, A
    MEDIZINISCHE KLINIK, 2005, 100 (04) : 232 - 232
  • [6] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [7] The safety and efficacy of Omalizumab in chronic idiopathic/dpontaneous urticaria: Results from a phase iii randomized, double-blind, placebo-controlled study
    Katelaris, C. H.
    Maurer, M.
    Staubach, P.
    Ashby, M.
    Canvin, J.
    Ledford, D.
    Kaplan, A.
    Jakob, T.
    Rosen, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 37 - 37
  • [8] Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study
    Kerscher, Martina
    Rzany, Berthold
    Prager, Welf
    Turnbull, Catriona
    Trevidic, Patrick
    Inglefield, Christopher
    DERMATOLOGIC SURGERY, 2015, 41 (10) : 1149 - 1157
  • [9] Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients
    de Souza, Savio Bastos
    Cabral, Paula Gebe Abreu
    da Silva, Renato Martins
    Arruda, Raul Ferraz
    Cabral, Sheila Passos de Figueiredo
    de Assis, Aricia Leone Evangelista Monteiro
    Viana Junior, Antonio Brazil
    Degrave, Wim Maurits Sylvain
    Moreira, Aline dos Santos
    Silva, Cleber Gloria
    Chang, Junbiao
    Lei, Pingsheng
    FRONTIERS IN MEDICINE, 2023, 10
  • [10] Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: A double-blind, randomized, placebo-controlled study
    Santos, AF
    Keitel, E
    Bittar, AE
    Neumann, J
    Fuchs, FD
    Goldani, JC
    Fonseca, NA
    Prates, VC
    Zaffan, D
    Voegeli, C
    Kroth, L
    Steffenello, G
    Saitovitch, D
    Garcia, VD
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1194 - 1195
12345